Alec Stranahan
BofA Securities
William Pickering
Bernstein Research
Whitney Ijem
Canaccord Genuity
Eric Schmidt, Ph.D.
Cantor Fitzgerald
Samantha Semenkow, Ph.D.
Citi Research
Bill Maughan, Ph.D.
Clear Street Research
Cory Kasimov
Evercore ISI
Debjit Chattopadhyay, Ph.D.
Guggenheim Securities
Patrick R. Trucchio, CFA
H.C. Wainwright & Co.
Maury Raycroft, Ph.D.
Jefferies
Brian Cheng
J.P. Morgan
Mani Foroohar, M.D.
Leerink Partners
Luca Issi, Ph.D.
RBC Capital Markets
Mike Yee
UBS
David Nierengarten, Ph.D.
Wedbush Securities
Yanan Zhu, Ph.D.
Wells Fargo Securities
Sami Corwin, Ph.D.
William Blair
Beam Therapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Beam Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Beam Therapeutics or its management. Beam Therapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.